GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)

NCT05632354 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
47
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated as data obtained from this non-placebo-controlled trial may not be informative for the interpretation of the benefits and risks of osivelotor

Conditions

Interventions

Sponsor

Pfizer